|
As part of post-market clinical follow-up (pmcf) registry for vxt and flixene grafts the following adverse event information was provided regarding a vxt graft.The patient implanted with an advanta graft developed a bypass graft infection, characterized by wound dehiscence and purulent discharge along the prosthesis.The patient underwent wound debridement and tissue sampling.Microbiological testing identified klebsiella pneumoniae and enterococcus faecium.The adverse event outcome was reported as resolved with sequelae.Surgical intervention was performed, and graft reintervention was required.On (b)(6) 2021, an explant procedure was performed due to the graft infection.During explantation, the prosthesis fractured, resulting in a small fragment remaining in the thigh.Surgical intervention was successful.
|